KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY;ENZYCHEM LIFESCIENCES CORPORATION
发明人:
Jae Wha Kim,Sei-Ryang Oh,Kyung Seop Ahn,Ho Bum Kang,Jae Mine Yoo,Tae-Suk Lee,JongKoo Kang,Hye Kyung Kim,Jin Soo Yook,Yong-Hae Han,Ki Young Sohn
申请号：
US14915799
公开号：
US09763908B2
申请日:
2014.09.03
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The present invention relates to a pharmaceutical composition, functional health food composition, quasi-drug composition, and cosmetic composition containing a monoacetyldiacylglycerol compound as an active ingredient for preventing, treating or improving atopic dermatitis. The monoacetyldiacylglycerol compound of the present invention has an excellent effect of suppression of IL-4 and IgE secretion, thereby overcoming side effects of an atopic dermatitis treatment agent currently in use, having no toxicity, and exhibiting an excellent treatment effect, and thus can be useful as a composition for preventing, treating, and ameliorating atopic dermatitis.
